Tomivosertib (eFT508)

tomivosertib · Effector Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tomivosertib (eFT508), covering 2024-06-21 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer [Phase 2]

See pricing